Is Oil’s 7% Crash Giving This Rally a Foundation It Can’t Sustain?

Crude oil’s 7% collapse is doing most of the heavy lifting Monday, engineering a broad risk-on session that has the Dow Jones Industrial Average up more than 1% and small caps outperforming — but the rally’s durability hinges entirely on a geopolitical situation that could reverse before the closing bell.

What Is Actually Driving the Tape

The proximate cause is energy. Crude oil’s roughly 7% intraday decline — the sharpest single-session drop in months — traces directly to reports that President Trump signaled to Israeli Prime Minister Benjamin Netanyahu that diplomatic channels with Tehran should get more runway before any military escalation. Markets read that as a reduction in supply-disruption risk, and the algorithmic response was instant: sell energy, buy everything that benefits from lower input costs.

The S&P 500 sits at 7,624 at midday, up 0.58% from Friday’s close of 7,580.07 and 0.18% above its open of 7,610.83. The Dow leads at approximately 52,314, up 1.05%. The Russell 2000 is the quiet outperformer at +1.06%, a signal worth tracking — small caps tend to benefit disproportionately from lower energy costs given their tighter operating margins. The Nasdaq Composite is up about 0.75%, though Oracle’s 4.99% drop is applying visible drag to the technology complex.

One additional macro pillar is holding this move together. The ISM manufacturing PMI climbed to 55.5 in October, above the 54.6 consensus estimate and up from September’s 54.5. Any reading above 50 signals expansion, and 55.5 is comfortably in growth territory. That data point matters because it contradicts the recessionary narrative that has shadowed this market through October. As we covered in our earlier analysis of whether manufacturing data can sustain this rally, the key question is whether the ISM strength reflects genuine demand or a pre-election inventory build — a distinction that will only become clear in coming weeks.

Data Visual

Midday Index Performance vs. Previous Close — November 2, 2026

Shows how each major U.S. index is performing against Friday’s close at midday, revealing the breadth and leadership of today’s risk-on move.

Values in %

The Movers That Define the Session

IDEXX Laboratories (IDXX) is the earnings story of the day. Shares jumped 20.1% to $661.77 after the veterinary diagnostics company reported Q3 earnings of $4.01 per share against a $3.71 consensus estimate — an 8% beat — alongside quarterly sales of $1.214 billion that topped the $1.191 billion forecast. The company also raised its full-year 2026 guidance above street estimates. A 20% single-session gain on those numbers is a large reaction for a company of IDEXX’s size and institutional following, suggesting the market had become overly cautious on pet healthcare spending heading into the print.

Inovio Pharmaceuticals (INO) is in a different category entirely. The stock surged 224% after the FDA granted accelerated approval for Voceryq, its plasmid DNA-based immunotherapy for recurrent respiratory papillomatosis — the first of its kind. Inovio expects to begin shipping within 60 days, with a full commercial launch in Q1 2027. The accelerated approval pathway means the FDA relied on a reduction in surgical frequency as an intermediate endpoint, not a survival benefit — that nuance matters for anyone sizing a position. For the full picture on what this means beyond the headline move, see our dedicated analysis of the Inovio catalyst.

Amazon (AMZN) is rallying more than 4% as investors reassess cloud growth metrics, adding meaningful weight to both the S&P 500 and Nasdaq given the stock’s index footprint. On the other side, Oracle (ORCL) is down 4.99% after announcing a combined $20 billion in stock and bond offerings — $10 billion of each. Dilution risk plus debt issuance in the same announcement is the kind of double-hit that warrants a sharp market response, and Oracle got one.

In M&A, Marvell Technology (MRVL) agreed to acquire optical chipmaker Lumentum (LITE) in a $115 billion all-stock transaction that would give Lumentum holders about 33% of the combined company and a 23.9% premium to Lumentum’s October 28 close. The deal projects more than $1 billion in annual cost synergies and is expected to be accretive to Marvell’s non-GAAP earnings per share within the first year. A deal of this scale, executed in all-stock currency, signals that Marvell’s management views its own shares as a strong enough asset to fund a transformational acquisition — a read on AI-infrastructure confidence that the rest of the chip sector should not ignore.

Data Visual

S&P 500 Sector Performance at Midday — Leaders vs. Laggards

Highlights which sectors are capturing inflows and which are bleeding, with energy and technology the clearest casualties of today’s rotation.

Values in %

Where the Money Is Actually Rotating

The sector picture tells a clear story of energy pain funding consumer and financial gains. Consumer discretionary, materials, and financials are the day’s leaders, each benefiting directly or indirectly from the oil price drop. Lower energy costs compress input-cost pressures for manufacturers and lift real consumer purchasing power — logic that markets are pricing immediately, even if the economic transmission takes quarters to materialize.

Energy is the session’s clearest loser. The United States Oil Fund (USO) has dropped 6.46%, dragging the State Street Energy Select Sector SPDR ETF (XLE) down 2.66%. Technology and healthcare are also in the red, with Oracle’s dilution shock adding fuel to tech’s decline and the broader healthcare complex digesting mixed earnings signals.

Gold is up 1.97% to $3,975.80 — a data point that complicates the pure risk-on narrative. Gold rallying alongside equities suggests some investors are hedging the geopolitical uncertainty even as they participate in the equity upside. The 10-year Treasury yield has slipped 4 basis points to 4.94%, a mild bond rally that supports the equity multiple but remains well inside the 5.00% level that would signal genuine macro stress. The fact that the yield is near 5% at all, despite today’s softness, is a structural constraint on how far the P/E expansion argument can run this quarter. We examined this dynamic in detail in our morning note on why the VIX was spiking even as Nasdaq futures climbed — the tension between rate levels and equity valuations has not resolved.

What to Watch Before the Close

The afternoon setup has three moving parts. First, any update on Middle East diplomatic talks could reverse the crude trade instantly — oil is the load-bearing wall of today’s rally, and it is built on a rumor, not a treaty. Second, tomorrow’s midterm elections create an unusual asymmetry: Trump’s reported decision to hold off on further strikes until after the vote means the next 24 hours of geopolitical news flow could be unusually quiet, or unusually loud. Third, watch whether Amazon’s 4% gain holds into the close; if institutional desks take profits on that move late in the session, the Nasdaq’s performance could fade toward the S&P’s more modest gains.

The S&P 500’s all-time high sits at 7,844.67, set in October 2026. Today’s midday level of 7,624 puts the index roughly 2.8% below that peak — close enough that a sustained rally could test it within weeks, but far enough that the bulls need a catalyst beyond a single day’s oil move to make that case credibly.

Monday’s session is a genuine broad rally — four major indices in the green, small caps participating, and manufacturing data providing a macro underpinning. But the composition of the move warrants skepticism about its durability. Geopolitical-driven commodity collapses have a history of retracing sharply when diplomatic optimism collides with ground-level reality. Traders who are long consumer discretionary and financials into the close are effectively short geopolitical escalation — a position that pays well until it doesn’t. The afternoon setup favors holding gains rather than chasing them.

Want our briefings first? Add PreMarket Daily as a preferred source on Google to see more of our coverage in Top Stories.